I cannot for the life of me see how ANYBODY can put a fundamental share value on MBP. It is all based on smoke and mirrors at the moment. They have not earned a cent, and as they cannot manufacture or distribute any of the drugs themselves, then any valuation of their shares HAS to take into account whatever deal they can do with a pharmaceutical major. To try and value their shares on anything else is pure guesswork and optimism.
That's why I think the Cohen report is pure ramping, nothing less.
I don't hold MBP.
MBP Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
